Concepedia

Author

B‐M Frost

Uppsala University Hospital

Also Known As

B Frost, B M Frost, B-M Frost, B. -M. Frost, B. Frost, B. M. Frost, B.-M. Frost, B.‐M. Frost, BM Frost, B‐M Frost

20

Publications

444

Citations

12

H-Index

34

Concepts

All Affiliations

Uppsala University HospitalUmeå UniversityUniversity of HelsinkiKarolinska University HospitalKarolinska Institutet
BF

About

B‐M Frost is an author at Uppsala University Hospital specializing in medicine, pediatrics, and neuropathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

104

2

Education

1

1

14

3

Public Health

1

1

31

4

Child Development

1

1

14

5

Early Childhood Education

1

1

14

B‐M Frost

×

9

Publications

340

Citations

9

H-Index

YearCitations

Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: Multi‐institutional collaborative study

B‐M Frost, Staffan Eksborg, Olle Björk,

Medical and Pediatric Oncology

2002

96

Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents

B‐M Frost, Gudmar Lönnerholm, P Koopmans,

Acta Paediatrica

2003

50

Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia

B‐M Frost

Blood

2004

47

Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92

TM Calero Moreno, Göran Gustafsson, Stanislaw Garwicz,

Leukemia

2002

47

Neonatal screening for sickle cell diseases in Camberwell: results and recommendations of a two year pilot study.

M E Horn, Moira Dick, B‐M Frost,

BMJ

1986

31

Cellular drug sensitivity in <i>MLL</i>‐rearranged childhood acute leukaemia is correlated to partner genes and cell lineage

Josefine Palle, B‐M Frost, Erik Forestier,

British Journal of Haematology

2005

31

The National Childhood Encephalopathy study: a 10-year follow-up. A report on the medical, social, behavioural and educational outcomes after serious, acute, neurological illness in early childhood.

Nicola Madge, James G. Diamond, Del D. Miller,

PubMed

1993

14

In vitro activity of the novel cytotoxic agent CHS 828 in childhood acute leukemia

B‐M Frost, Gudmar Lönnerholm, Per‐Åke Nygren,

Anti-Cancer Drugs

2002

12

Use of intrathecal chemoprophylaxis in children after SCT and the risk of central nervous system relapse

J. Peter Rubin, Kim Vettenranta, J Vettenranta,

Bone Marrow Transplantation

2010

12

Page 1